Clincosm LogoSign in Get a demo

Norovirus

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers, Norovirus Trial in Belgium, United States (NoV Vaccine)

Completed
Has Results
  • Healthy Volunteers
  • Norovirus
  • NoV Vaccine
  • Birmingham, Alabama
  • +10 more
Nov 7, 2022

Norovirus Trial in Ghent (Norovirus GI.4 / GII.4 Bivalent VLP Vaccine (100 µg), Norovirus GI.4 / GII.4 Bivalent VLP Vaccine (300

Completed
  • Norovirus
  • Norovirus GI.4 / GII.4 Bivalent VLP Vaccine (100 µg)
  • +2 more
  • Ghent, Belgium
    Center for Vaccinology (CEVAC), Ghent University and University
Aug 18, 2022

Norovirus Trial in United States (Norovirus GI.1/GII.4 Bivalent VLP Vaccine, 0.9% sodium chloride (saline))

Completed
Has Results
  • Norovirus
  • Norovirus GI.1/GII.4 Bivalent VLP Vaccine
  • 0.9% sodium chloride (saline)
  • Birmingham, Alabama
  • +9 more
Apr 22, 2020

Norovirus Trial in Colombia, Finland, Panama (GI.1/GII.4 (15/15), GI.1/GII.4 (15/50), GI.1/GII.4 (50/50))

Completed
Has Results
  • Norovirus
  • GI.1/GII.4 (15/15)
  • +4 more
  • Cali, San Fernando, Colombia
  • +11 more
Dec 21, 2018

Norovirus, Healthy Participants Trial in Austin (NoV GI.1/GII.4 Bivalent VLP Vaccine)

Completed
Has Results
  • Norovirus
  • Healthy Participants
  • NoV GI.1/GII.4 Bivalent VLP Vaccine
  • Austin, Texas
    Benchmark Research Austin
Feb 16, 2018

Norovirus Trial in United States (drug, device, biological)

Completed
  • Norovirus
  • Baltimore, Maryland
  • +3 more
May 5, 2015